Longeveron Inc.: chief medical officer steps down

What happened Longeveron Inc filed an 8-K reporting that Dr. Nataliya Agafonova informed management on Oct 7, 2026 that she would step down as chief medical officer, to become effective Oct 14, 2026.

Key details

• Form 8-K filed Oct 14, 2026 (Accession: 0001213900-26-109411).
• Insider: Dr. Nataliya Agafonova.
• Date Dr. Agafonova informed management: Oct 7, 2026.
• Effective date of stepping down: Oct 14, 2026.
• Item reported: Item 5.02 (Departure of directors or certain officers; election of directors).

Why it may matter This filing reports Item 5.02, which covers the departure of directors or certain officers; the 8-K states that Dr. Agafonova will step down as chief medical officer effective Oct 14, 2026. A filing does not show why the insider traded or why the company acted.